CARTILAGE NEOPLASM

This adverse event was reported 23 times

CARTILAGE NEOPLASM is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 MECASERMIN 1 0.0012
1 PAMIDRONATE DISODIUM 1 0.0003
2 TOLTERODINE TARTRATE 1 0.0001
3 NAPROXEN SODIUM, PSEUDOEPHEDRINE HYDROCHLORIDE 2 0.0001
4 GOLIMUMAB 1 0.0001
5 CARISOPRODOL 1 0.0001
6 PAROXETINE HYDROCHLORIDE 2 0.0000
7 METRONIDAZOLE TOPICAL 2 0.0000
8 CONJUGATED ESTROGENS 2 0.0000
9 ESTROGENS, CONJUGATED 2 0.0000
See all drugs enriched for association with CARTILAGE NEOPLASM

CARTILAGE NEOPLASM is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Recombinant Human Growth Hormone [EPC] 1 0.0000
1 Nitroimidazole Antimicrobial [EPC] 2 0.0000
2 Muscle Relaxant [EPC] 1 0.0000
3 Complement Inhibitor [EPC] 1 0.0000
4 Aromatase Inhibitor [EPC] 2 0.0000
5 Estrogen [EPC] 2 0.0000
6 Expectorant [EPC] 2 0.0000
7 Parathyroid Hormone Analog [EPC] 1 0.0000
8 Proteasome Inhibitor [EPC] 1 0.0000
9 Opioid Agonist [EPC] 2 0.0000
See all drug classes enriched for association with CARTILAGE NEOPLASM